These findings provide evidence that HDAC2 is significantly upregulated in lung adenocarcinoma cells and is closely associated with the overall survival of lung adenocarcinoma patients, suggesting that HDAC2 may exert a pivotal role in the progression of lung adenocarcinoma and could represent a promising therapeutic target. Here, HDAC2 is linked to lung adenocarcinoma.